These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16753886)

  • 41. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T; Babusíková O
    Neoplasma; 2005; 52(6):517-22. PubMed ID: 16284699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Superior vena cava syndrome as initial symptom of Vasculo-Behçet's disease--case report].
    Ichikawa M; Kobayashi H; Mukai M; Saitoh Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Oct; 29(10):1344-8. PubMed ID: 1753515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunophenotypic profile of adult acute myeloid leukemia (AML): analysis of 267 cases in Thailand.
    Auewarakul CU; Promsuwicha O; U-Pratya Y; Pattanapanyasat K; Issaragrisil S
    Asian Pac J Allergy Immunol; 2003 Sep; 21(3):153-60. PubMed ID: 15032399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An early sign of superior vena cava syndrome.
    Wieser S; Kohler M
    QJM; 2010 Sep; 103(9):707. PubMed ID: 19910456
    [No Abstract]   [Full Text] [Related]  

  • 45. [Malign obstruction of the superior vena cava].
    Domínguez MA; Manterola A; Romero P; Martínez E; Arias F; Villafranca E; Martínez M
    An Sist Sanit Navar; 2004; 27 Suppl 3():99-107. PubMed ID: 15723109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Malignant stenosis of the superior vena cava].
    Stverák P; Skotnicová S; Vodvárka P; Martínek A; Häringová M; Matoska P; Stolarová I
    Cas Lek Cesk; 2000 Jul; 139(13):408-10. PubMed ID: 10971971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-DR antigen-negative acute myeloid leukemia.
    Wetzler M; McElwain BK; Stewart CC; Blumenson L; Mortazavi A; Ford LA; Slack JL; Barcos M; Ferrone S; Baer MR
    Leukemia; 2003 Apr; 17(4):707-15. PubMed ID: 12682628
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unilateral superior vena cava syndrome.
    Desai UD; Joshi JM
    J Postgrad Med; 2014; 60(4):390-3. PubMed ID: 25370548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of CD34 epitopes in AML.
    Sutherland R; Keeney M; Gratama JW
    Haematologica; 2003 Jun; 88(6):ELT22; author reply ELT23. PubMed ID: 12801861
    [No Abstract]   [Full Text] [Related]  

  • 51. [Superior vena cava syndrome: report of a case].
    Chang BF; Hung KL; Wang NK; Chen TH; Huang SS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1988; 29(5):357-62. PubMed ID: 3272536
    [No Abstract]   [Full Text] [Related]  

  • 52. [The superior vena cava syndrome in retrosternal goiter].
    Kessler Sáiz P; Olmedo Moreno M; Jareño Chaumel J; Pascual Cuesta T
    An Med Interna; 1989 Sep; 6(9):479-80. PubMed ID: 2562723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Superior vena cava syndrome.
    Wan JF; Bezjak A
    Emerg Med Clin North Am; 2009 May; 27(2):243-55. PubMed ID: 19447309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
    Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
    Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
    Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enlarged and prominent nucleus may be indicative of tetraploidy: a laboratory study of a rare near-tetraploidy in a child patient with acute myelogenous leukemia AML-M4.
    Zhang JH; Zheng YC; Wang YX; Zhang JY; Liu ZG
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):19-21. PubMed ID: 19816206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superior vena cava syndrome and ovarian hyperstimulation syndrome.
    Tal Y; Haber G; Cohen MJ; Phillips M; Revel A; Varon D; Ben-Yehuda A
    Isr Med Assoc J; 2009 Aug; 11(8):503-4. PubMed ID: 19891241
    [No Abstract]   [Full Text] [Related]  

  • 59. Cutaneous findings leading to a diagnosis of superior vena cava syndrome: A case report and review of the literature.
    Ratnarathorn M; Craig E
    Dermatol Online J; 2011 Jun; 17(6):4. PubMed ID: 21696684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Superior vena cava syndrome--potential of the intervention therapy].
    Beran S
    Cas Lek Cesk; 2006; 145(5):349-52. PubMed ID: 16755768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.